Drug & Supplement Interactions
SAMe + Tucatinib
Brand name of Tucatinib
- Tukysa
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team
Updated October 2026Details about this page
- Pair last verified Nov 22, 2026
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- Our sources →
AI is used only to summarize verified clinical information, never the open internet. Our AI policy
We found no known interaction between SAMe and Tucatinib in our sources.
This also applies to Tukysa, a brand name of tucatinib.
Still Worth Knowing
- Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
Ask a Question About This Combination
Ask in your own words about taking SAMe with Tucatinib. The answer comes from this page’s own records.
AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI
SAMe and Tucatinib Interaction Check
No Known Interaction Found
We did not find a documented interaction between Tucatinib and SAMe in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
How We Checked
Why No Interaction Is Listed for Tucatinib
We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Tucatinib is in against every category SAMe has a known interaction with.
7Categories Tucatinib Is In
- Tucatinib by Name Interactions recorded for Tucatinib itself rather than for a category. No SAMe Record
- Cytochrome P450 2C8 (Cyp2C8) Substrates Drugs the body breaks down mainly with the liver enzyme CYP2C8; when something slows or speeds up that enzyme, their levels in the blood can rise or fall. No SAMe Record
- Cytochrome P450 3A4 (Cyp3A4) Inhibitors Drugs that slow the liver enzyme CYP3A4, which can raise the levels of other drugs that enzyme breaks down. No SAMe Record
- P-Glycoprotein Substrates Drugs that a pump called P-glycoprotein moves out of cells in the gut, liver and kidneys; when the pump slows or speeds up, their levels can rise or fall. No SAMe Record
- Hepatotoxic Drugs Drugs that can harm the liver in some people, such as high doses of acetaminophen, isoniazid, methotrexate and valproate. No SAMe Record
- Cytochrome P450 3A4 (Cyp3A4) Substrates Drugs the body breaks down mainly with the liver enzyme CYP3A4; when something slows or speeds up that enzyme, their levels in the blood can rise or fall. No SAMe Record
- Oral Drugs Any drug taken by mouth. No SAMe Record
2Drug Categories SAMe Interacts With
No overlap. Tucatinib is in none of the 2 categories SAMe interacts with, so no record links the two.
- Add one new thing at a time, and note the date you started it.
- A start date turns “I’ve been feeling off” into something a pharmacist can work with.
- Do not stop a prescribed medicine on your own.
- Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Studies That Mention Both SAMe and Tucatinib
lists 8 records naming both. These are the most relevant that discuss the two together. Mentioning both is not a finding about taking them together, so treat them as a starting point.
- A study to learn how well tucatinib plus trastuzumab works for treating participants with metastatic colorectal cancer, and how safe it is: a plain language summary of the MOUNTAINEER study. Future Oncology (London, England) · 2024 · In people · PMID 37941353
- Tucatinib has Selective Activity in HER2-Positive Cancers and Significant Combined Activity with Approved and Novel Breast Cancer-Targeted Therapies. Molecular Cancer Therapeutics · 2022 · In people · PMID 35417017
- Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer. Expert Review of Pharmacoeconomics & Outcomes Research · 2026 · In people · PMID 41789524
Other Records That Name Both
These name both, but never in the same sentence or only in a lab method, so they may be about something else.
- Sequential Therapy With HER2 Tyrosine Kinase Inhibitors in Patients With HER2-Positive Metastatic Breast Cancer. Clinical Breast Cancer · 2025 · In people · PMID 40610321
- Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2. Breast Care (Basel, Switzerland) · 2020 · Review · PMID 33447231
- In-Silico identification and optimization of therapeutic peptides against breast cancer via transcriptomic profiling. Molecular Diversity · 2026 · In people · PMID 41483317
- Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review. Antibodies (Basel, Switzerland) · 2026 · Review · PMID 42041395
- Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry. Analytical Methods · 2026 · PMID 42885763
Reports to the FDA
2 reports to the FDA list both SAMe and Tucatinib.
What this means: someone took both, then had a health problem. It does not show either one caused it. In 2 of the 2 newest reports, SAMe or Tucatinib was the suspect or was flagged as interacting. The reports below say which.
- 2Reports that list both
- 2Marked serious by the reporter
- 2From doctors, pharmacists and other health professionals
- 0From patients and other consumers
The 2 Newest Reports
Who sent them, what happened and which medicine was suspected
| Received | Reported by | What happened | Medicine suspected | SAMe | Tucatinib |
|---|---|---|---|---|---|
| January 2025Report 24873734 | A physician | Gamma-glutamyltransferase increased, Dermatitis atopicSerious: hospital stay | Xyzal, Tucatinib and 6 more21 products listed | Also taking | Suspected |
| August 2023Report 22876519 | A physician | Liver problems (hepatic function abnormal)Serious: hospital stay | Tucatinib, Ado-trastuzumab Emtansine10 products listed | Also taking | Suspected |
Problems Named Most Often
Across all 2 reports, whatever was suspected. Not what this pair causes.
- Dermatitis atopic1
- Gamma-glutamyltransferase increased1
- Liver problems (hepatic function abnormal)1
How we searched
PubMed: searched November 2026, and again every few months. PubMed lists research but does not grade it; the finding above comes from our interaction records.
FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read November 2026. Matched by name, so a report may name a product that contains SAMe. The counts are reports, not people, and no one checks them for cause. What FAERS is.
Your Whole Routine
Your Other Medicines and Supplements
SAMe Does Interact With Other Medications
SAMe has 189 moderate known drug interactions in our database — Tucatinib isn’t one of them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against SAMe
We haven’t checked that one against SAMe yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against SAMe. Pick one to open its full report.
Other Supplements for the Same Uses as SAMe, and How They Mix With Tucatinib
Choosing a supplement while you take Tucatinib? Pick what you use SAMe for to see other options studied for it, and whether each has a documented interaction with Tucatinib.
What do you take SAMe for?
For Osteoarthritis
4 of them have a documented interaction with Tucatinib: Boswellia Serrata (moderate), Devil's Claw (moderate), Ginger (moderate) and Turmeric (moderate).
21 other supplements have at least some evidence of a benefit for osteoarthritis; the 8 below come first. SAMe itself is graded for it.
- Boswellia Serrata Graded Moderate
- Devil's Claw Graded Moderate
- Ginger Graded Moderate
- Turmeric Graded Moderate
- Glucosamine Graded No Known Interaction
- Andrographis Graded No Known Interaction
- Arnica Graded No Known Interaction
- Avocado Soy Unsaponifiables (asu) Graded No Known Interaction
For Depression
2 of them have a documented interaction with Tucatinib: St. John's Wort (major) and Dhea (moderate).
10 other supplements have at least some evidence of a benefit for depression; the 8 below come first. SAMe itself is graded for it.
- St. John's Wort Graded Major
- Dhea Graded Moderate
- 5-htp Graded No Known Interaction
- Acetyl-l-carnitine Graded No Known Interaction
- Ba Ji Tian Graded No Known Interaction
- Eicosapentaenoic Acid (epa) Graded No Known Interaction
- Folic Acid Graded No Known Interaction
- Lemon Balm Graded No Known Interaction
The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.
See Every Supplement That Interacts With Tucatinib
Take other supplements too? 182 supplements have a documented interaction with Tucatinib, each explained on its page.
By severity: 6 major, 140 moderate and 36 minor.
The Most Serious There Right Now:
- Activated Charcoal and TucatinibMajor
- Beer and TucatinibMajor
- Grapefruit and TucatinibMajor
- Siberian Cocklebur and TucatinibMajor
- St. John's Wort and TucatinibMajor
Taking SAMe as Part of a Dietary Supplement Product? Check It for Interactions
A product can hold more than SAMe. We have broken down 9 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Tucatinib:
SAMe Products People Look Up
Get to Know Each One
About SAMe and Tucatinib
About SAMe
SAM-e is a compound your body makes naturally that is sold as a supplement, most often for depression and osteoarthritis. Some research suggests it may help with these conditions, but the quality of evidence is mixed and more study is needed. Talk with your pharmacist or doctor before trying it, especially if you take other medicines or have bipolar disorder.
On Its Own
SAMe Safety
How SAMe Is Rated
-
SAMe Overall
Use caution
Often well tolerated short-term, but it can cause stomach upset and may trigger mania in people with bipolar disorder.
-
Pregnancy
Possibly Safe
When used intravenously short-term during the third trimester of pregnancy.
Read the full pregnancy detail ↓ -
Breastfeeding
Not established
There is not enough reliable information, so caution is advised.
Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.
SAMe in Pregnancy & Breastfeeding
When used intravenously short-term during the third trimester of pregnancy. In two small-scale trials, SAMe 800 mg daily was used intravenously for 14-20 days during the third trimester of pregnancy for cholestasis. No adverse effects were observed. However, use of SAMe in pregnancy should only be considered when benefits clearly outweigh the potential risks. There is insufficient reliable information available about the use of SAMe at higher doses, for extended periods of time, or during the earlier trimesters of pregnancy.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center
About Tucatinib
Brand name: Tukysa
Tucatinib (sold as Tukysa tablets) is always used together with other cancer medicines. It is for adults whose cancer is HER2-positive and has spread or cannot be removed by surgery.
More to Explore
More Pairs and Interactions to Check
Other Supplements People Check With Tucatinib
More pair pages for Tucatinib: the rest of its documented supplement interactions first, then supplements with none on record, the most looked-up leading.
- WineMajor›
- Vitamin EModerate›
- Vitamin AModerate›
- GingerModerate›
- TurmericModerate›
- Green TeaModerate›
Show all 25 supplementsShow fewer
- AshwagandhaModerate›
- Black PepperModerate›
- GrapeModerate›
- GinkgoModerate›
- LicoriceModerate›
- BeetModerate›
- QuercetinModerate›
- Cannabidiol (cbd)Moderate›
- Cannabigerol (cbg)Moderate›
- Cannabinol (cbn)Moderate›
- Ceylon LeadwortModerate›
- Chanca PiedraModerate›
- ChaparralModerate›
- Vitamin CNo Known Interaction›
- CalciumNo Known Interaction›
- Vitamin B6No Known Interaction›
- AckeeNo Known Interaction›
- AconiteNo Known Interaction›
- Active Hexose Correlated Compound (ahcc)No Known Interaction›
Other Drugs & SAMe
Browse every other medication we’ve checked against SAMe — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
Also checked against SAMe
Moderate: 189 interactions
- Methylphenidate ›
- Fentanyl ›
- Carbamazepine ›
- Dextromethorphan ›
- Phenylephrine ›
- Trimipramine ›
- Buprenorphine ›
- Nortriptyline ›
- Selegiline ›
- Sumatriptan Succinate ›
- Aripiprazole ›
- Cyclobenzaprine ›
- Desipramine ›
- Doxepin ›
- Duloxetine ›
- Metoclopramide ›
- Paroxetine ›
- Prucalopride ›
- Tramadol ›
- Valproic Acid ›
- Vortioxetine ›
- Almotriptan ›
- Aripiprazole Lauroxil ›
- Chlorpheniramine ›
- Clozapine ›
- Desvenlafaxine ›
- Dexchlorpheniramine ›
- Dihydroergotamine ›
- Fluoxetine ›
- Granisetron ›
- Belladonna Alkaloids, Chlorpheniramine, Phenylephrine, and Phenylpropanolamine ›
- Benzhydrocodone and Acetaminophen ›
- Benzocaine and Dextromethorphan ›
- Brompheniramine, Dextromethorphan, and Phenylephrine ›
- Buproprion and Dextromethorphan ›
- Carbetapentane Tannate and Chlorpheniramine Tannate ›
- Carbetapentane, Chlorpheniramine, and Phenylephrine ›
- Carbetapentane, Chlorpheniramine, Phenylephrine, Phenylpropanolamine, and Potassium Guaiacolsulfonate ›
- Carbidopa, Levodopa, and Entacapone ›
- Celecoxib and Tramadol ›
- Chlorpheniramine Maleate and Hydrocodone Bitartrate ›
- Chlorpheniramine Polistirex and Codeine Polistirex ›
- Chlorpheniramine Tannate and Phenylephrine Tannate ›
- Chlorpheniramine, Hydrocodone, and Pseudoephedrine ›
- Chlorpheniramine and Methscopolamine ›
- Chlorpheniramine, Methscopolamine, and Phenylpropanolamine ›
- Chlorpheniramine, Phenindamine, and Phenylpropanolamine ›
- Chlorpheniramine, Phenylephrine, and Phenylpropanolamine ›
- Chlorpheniramine, Phenylephrine, and Pyrilamine ›
- Chlorpheniramine, Pheylephrine, and Pyrilamine ›
- Chlorpheniramine, Pyrilamine, and Phenylephrine ›
- Dextromethorphan Hbr and Phenylephrine Hcl ›
- Dextromethorphan, Guaifenesin, and Phenylpropanolamine ›
- Dextromethorphan, Guaifenesin, and Psuedoephedrine ›
- Dextromethorphan, Methscopolamine, and Phenylephrine ›
- Dextromethorphan and Pseudoephedrine ›
- Dextromethorphan, Pseudoephedrine, and Triprolidine ›
- Fentanyl Citrate and Oral Transmucosal Fentanyl Citrate ›
- Fosnetupitant and Palonosetron (iv) ›
- Hydrocodone, Pseudoephedrine, and Chlorpheniramine ›
Showing 60 of 189 moderate interactions — see all 189 on the SAMe page.
No Interaction 2,640 drugs checked — show the list
We also checked SAMe against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Warfarin ›
- Levothyroxine ›
- Amlodipine ›
- Clopidogrel ›
- Rosuvastatin ›
- Losartan Potassium ›
- Aspirin ›
- Atorvastatin ›
- Levothyroxine and Liothyronine ›
- Warfarin Sodium ›
- Rivaroxaban ›
- Metformin ›
- Metoprolol ›
- Tirzepatide ›
- Tadalafil ›
- Ibuprofen ›
- Semaglutide ›
- Ivermectin ›
- Testosterone ›
- Amoxicillin ›
- Prednisone ›
- Acetaminophen ›
- Amphetamine ›
- Azithromycin ›
- Isotretinoin ›
- Abemaciclib ›
- Methotrexate ›
- Propranolol ›
- Pregabalin ›
- Isosorbide Dinitrate ›
- Isosorbide Mononitrate ›
- Isoxsuprine ›
- Isradipine ›
- Istradefylline ›
- Itraconazole ›
- Ivabradine ›
- Ivacaftor ›
- Ivosidenib ›
- Ixabepilone ›
- Ixazomib Citrate ›
- Ixekizumab ›
- Kanamycin ›
- Ketamine ›
- Ketazolam ›
- Ketoconazole ›
- Ketoprofen ›
- Ketorolac Tromethamine ›
- Ketotifen ›
- L-glutamine (prescription Drug) ›
- Labetalol ›
- Lacosamide ›
- Lactitol ›
- Lactulose ›
- Lamivudine ›
- Lanadelumab (shp643) ›
- Lanreotide ›
- Lansoprazole ›
- Lanthanum Carbonate ›
- Lapatinib ›
Showing 60 of the 2,640 medications checked with no known interaction, the most looked-up first — see the full SAMe list.
Where SAMe and Tucatinib Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#289 of 1,458 supplements looked up here in the last 7 days
#912 of 2,830 medications looked up here in the last 7 days
A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.
Keep Exploring
Questions and Sources
Common Questions and Where This Comes From
Taking SAMe and Tucatinib Together: Common Questions
Can you take SAMe with Tucatinib?
Can you take SAMe with Tukysa?
Do SAMe and Tucatinib have any of the same side effects?
How was the SAMe and Tucatinib combination checked?
Do other supplements studied for osteoarthritis interact with Tucatinib?
Does SAMe interact with any other medications?
Does Tucatinib interact with any supplements?
Has SAMe been studied with Tucatinib?
Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy
References Cited on This Page
The 16 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
Show the 16 references
- 5188. Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J Rheumatol 1994;21:905-11.
- 5195. Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry 1990;147:591-5. PubMed
- 5196. Rosenbaum JF, Fava M, Falk WE, et al. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand 1990;81:432-6. PubMed
- 5199. Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of ademetionine vs naproxen in activated gonarthrosis. Int J Clin Pharmacol Ther Toxicol 1989;27:329-33.
- 5203. Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987;83:89-94. PubMed
- 5231. Friedel HA, Goa KL, Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989;38:389-416. PubMed
- 12231. Goren JL, Stoll AL, Damico KE, et al. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy 2004;24:1501-7. PubMed
- 14841. Arnold O, Saletu B, Anderer P, et al. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry. Eur Neuropsychopharmacol 2005; PubMed
- 20202. Kim J, Lee EY, Koh EM, et al. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients. Clin Ther 2009; PubMed
- 20204. Manzillo G, Piccinino F, Surrenti C, et al. Multicentre double-blind placebo-controlled study of intravenous and oral S-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease. Drug Invest 1992;4 (Suppl 4):90-100. DOI
- 20218. Carrieri PB, Indaco A, Gentile S, et al. S-adenosylmethionine treatment of depressioin in patients with Parkinson's disease: a double-blind, crossover study versus placebo. Curr Ther Res 1990;48(1):154-60.
- 20230. Medici V., Virata M. C., Peerson J. M., Stabler S. P., French S. W., Gregory J. F. III, Albanese A., Bowlus C. L., Devaraj S., Panacek E. A., Richards J. R., Halsted C. H. S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, ra
- 72978. Carney, M. W., Edeh, J., Bottiglieri, T., Reynolds, E. M., and Toone, B. K. Affective illness and S-adenosyl methionine: a preliminary report. Clin Neuropharmacol. 1986;9(4):379-385. PubMed
- 72988. Miccoli, L., Porro, V., and Bertolino, A. Comparison between the antidepressant activity and of S- adenosylmethionine (SAMe) and that of some tricyclic drugs. Acta Neurol (Napoli) 1978;33 (3):243-255.
- 73002. Muscettola G, Galzenati M, Balbi A. SAMe versus placebo: a double blind comparison in major depressive disorders. Advances in Biochemical Psychopharmacology 1982;32:151-6.
- 73035. Capretto C, Cremona C, and Canaparo L. A double-blind controlled study of S-adenosylmethionine (SAMe) v. ibuprofen in gonarthrosis, coxarthrosis and spondylarthrosis. Clin Trials J 1985;22(1):15-24.
All 31 references behind our SAMe records are listed in the SAMe guide.
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.
Where Does Our Data Come From?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified November 22, 2026. The SAMe and Tucatinib records this page draws on were last updated October 6, 2026.
What Our Interaction Ratings Mean
No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.
See what each severity means
Severity: How Serious Is It?
How clinically significant the interaction is: how much it could affect your health or your treatment.
- MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
- ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
- MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
- No Known InteractionNo documented interaction in our sources.
Still Have a Question About SAMe and Tucatinib?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.